Research uncovers a surprising prevalence of cardiovascular disease risk factors among adults in extreme poverty, challenging assumptions about lower risks due to their lifestyle and diet, and underscores the need for targeted health interventions and policies.
Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option.
January 27, 2024